iCo Therapeutics is an emerging Vancouver-based biotechnology company committed to developing drugs for a range of human medical conditions within €˜isolated biological environments €™, such as the eye, spinal cord or joints.
Focusing on these isolated biological systems allows a drug to reach commercialization faster and more efficiently since non-systemic (local) administration has the potential for fewer risks and safety issues.